ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
Hironori Uruga,1 Mari Mino-Kenudson2 1Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, Japan; 2Department of Pathology, Massachusetts General Hospital, Boston, MA, USA Abstract: Screening for anaplastic lymphoma kinase (ALK) rearrangements is a very important proces...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | |
| Опубликовано: |
Dove Medical Press,
2018-09-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |